Americas Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021

Americas Influenza Vaccines Market, Persons Vaccinated, Brand Analysis And Forecast To 2021

The influenza vaccines market in Americas is anticipated to reach nearly US$ 3 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.

In the Americas, United States captures majority of the influenza vaccines market share. Brazil is the second leading market for influenza vaccines with around XX% share in 2015. Canada and Mexico are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2015.

In the influenza vaccines brand sales segment, Sanofis Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSKs Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.

iGATE Research report titled "Americas Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021" provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 90 Page report contains 33 Figures and 8 Tables to present a clear picture of the influenza vaccines market landscape.

The Influenza Vaccines Market have been analyzed from 5 viewpoints:

1. Americas - Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2021)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)
3. Influenza Vaccines Brand Sales and Forecast to 2021
4. Influenza Vaccines Market - Major Deals
5. Influenza Vaccines Market - Driving Factors and Challenges

Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution

1. United States
2. Canada
3. Brazil
4. Mexico

Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed

1. Fluarix/FluLaval
2. Fluzone
3. Fluvirin/Flucelvax
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases

1. Executive Summary

2. Americas - Influenza Vaccines Market Analysis and Forecast (2011 - 2020)

2.1 Americas - Influenza Vaccines Market and Forecast (2011 - 2021)
2.2 Americas - Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011 - 2021)

3. Americas - Influenza Vaccines Market Share Analysis and Forecast

3.1 Influenza Vaccines Market Share and Forecast - Country Wise Analysis (2011 - 2021)
3.2 Persons Being Vaccinated with Influenza Vaccines Share and Forecast - Country Wise Analysis (2011 - 2021)

4. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)

4.1 United States - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.1.1 United States - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.1.2 United States - Influenza Vaccines Market and Forecast

4.2 Canada - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.2.1 Canada - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.2.2 Canada - Influenza Vaccines Market and Forecast

4.3 Brazil - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.3.1 Brazil - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.3.2 Brazil - Influenza Vaccines Market and Forecast

4.4 Mexico - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.4.1 Mexico - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.4.2 Mexico - Influenza Vaccines Market and Forecast

5. Influenza Vaccines Brand Sales and Forecast

5.1 Fluarix / FluLaval Sales and Forecast (2007 - 2021)
5.2 Fluzone Sales and Forecast (2009 - 2021)
5.3 Fluvirin/Flucelvax Sales and Forecast (2010 - 2021)
5.4 Influvac (Acquired by Abbott) Sales (2007 - 2009)
5.5 Afluria/Fluvax Sales and Forecast (2010 - 2021)
5.6 FluMist/Fluenz Sales and Forecast (2007 - 2021)
5.7 Flublok Sales and Forecast (2013 - 2021)

6. Influenza Vaccines Market - Major Deals

6.1 Mergers and Acquisitions
6.2 Licensing Agreements

7. Influenza Vaccines Market - Driving Factors

7.1 Transformation of Vaccine Technologies
7.2 Vaccines most Cost Effective Means of Disease Prevention
7.3 Scientific & Technological Breakthroughs
7.4 Continuous Focus on Effective Communication Strategies
7.5 Increasing Awareness on Seasonal Influenza & Vaccination

8. Influenza Vaccines Market - Challenges

8.1 Complexity of Vaccine Development and Approval System Thwarts Product Development

8.1.1 Legal Obstacles
8.1.2 General Technical Barriers
8.1.3 Economic Barriers
8.1.4 Regulatory Barriers

8.2 Hurdles to Optimal use of Licensed Vaccines

8.2.1 Technical Obstacles
8.2.2 Economic obstacles
8.2.3 Cultural Obstacles

8.3 Barriers to New Entrants in the Vaccines Market
8.4 Reducing the Timeline for Vaccine Development
8.5 Challenges Faced by Healthcare Workers in Immunization

List of Figures:

Figure 2-1: Americas - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 2-2: Americas - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 2-3: Americas - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 2-4: Americas - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021

Figure 4-1: United States - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-2: United States - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-3: United States - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-4: United States - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-5: Canada - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-6: Canada - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-7: Canada - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-8: Canada - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-9: Brazil - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-10: Brazil - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-11: Brazil - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-12: Brazil - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-13: Mexico - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-14: Mexico - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-15: Mexico - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-16: Mexico - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021

Figure 5-1: Global - Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2007 - 2015
Figure 5-2: Global - Forecast for Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-3: Global - Fluzone Influenza Vaccine Sales (Million US$), 2009 - 2015
Figure 5-4: Global - Forecast for Fluzone Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-5: Global - Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2009 - 2015
Figure 5-6: Global - Forecast for Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-7: Global - Influvac Influenza Vaccine Sales (Million US$), 2007 - 2009
Figure 5-8: Global - Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2010 - 2015
Figure 5-9: Global - Forecast for Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-10: Global - FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2007 - 2015
Figure 5-11: Global - Forecast for FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-12: Global - Flublok Influenza Vaccine Sales (Million US$), 2013 - 2015
Figure 5-13: Global - Forecast for Flublok Influenza Vaccine Sales (Million US$), 2016 - 2021

List of Tables:

Table 3-1: Country Wise - Influenza Vaccines Market Share (Percent), 2011 - 2015
Table 3-2: Country Wise - Forecast for Influenza Vaccines Market Share (Percent), 2016 - 2021
Table 3-3: Country Wise - Persons Vaccinated with Influenza Vaccines Share (Percent), 2011 - 2015
Table 3-4: Country Wise - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2016 - 2021

Table 6-1: Global - Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 - 2015
Table 6-2: Global - Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 - 2015

Table 7-1: Improvement Strategies or Requirements - the Joint Commission and the Projects Collaborating Organizations
Table 7-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009

Americas Influenza Vaccines Market, Persons Vaccinated, Brand Analysis And Forecast To 2021

PRICING

Categories